Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Mayo Clin Proc Retrieve available abstracts of 50 articles: HTML format

Single Articles

October 2025
1. MOON IT, Park YK, Yi HJ, Chun HJ, et al
   Long-term Outcomes of Hypertension and Antihypertensive Drugs in Healthy Young Adults: A Nationwide Population-Based Prospective Cohort Study in Korea.
   Mayo Clin Proc. 2025;100:1758-1770.
   PubMed     Abstract available
   
   
   September 2025
2. ZAHID S, Peng AW, Razavi AC, Yao Z, et al
   Does the New Clinical Obesity Definition Address the Obesity Paradox in Cardiovascular Health?
   Mayo Clin Proc. 2025 Sep 30:S0025-6196(25)00397.
   PubMed    
   
   
   August 2025
3. HALL ME, Khan LA, Javaid SS
   Cardiovascular Risk Factor Variability: Why Consistency Matters.
   Mayo Clin Proc. 2025;100:1285-1287.
   PubMed    
   
   
   
4. KUNUTSOR SK, Laukkanen JA
   Lessons From a Contemporary Cohort: Acute Kidney Injury After Percutaneous Coronary Intervention and the Need for Renewed Prevention Strategies.
   Mayo Clin Proc. 2025;100:1278-1280.
   PubMed    
   
   
   July 2025
5. PATEL N, Gaonkar M, Pampana A, Dhaliwal JS, et al
   Cardiovascular Health and Outcomes in Carriers With Genetic Variants of Hypertrophic Cardiomyopathy.
   Mayo Clin Proc. 2025 Jul 23:S0025-6196(24)00694.
   PubMed     Abstract available
   
   
   
6. KATTAH AG, Coutinho TD, Vermunt J, Vaughan LE, et al
   Blood Pressure Thresholds for Hypertension in Pregnancy and Future Cardiovascular Risk.
   Mayo Clin Proc. 2025 Jul 23:S0025-6196(25)00241.
   PubMed     Abstract available
   
   
   
7. SALEH AK, Bowman SE, Scheinuk JE, Josey G, et al
   Impact of Social Determinants of Health on Atherosclerotic Cardiovascular Disease in Transgender Individuals.
   Mayo Clin Proc. 2025 Jul 7:S0025-6196(25)00028.
   PubMed     Abstract available
   
   
   
8. TAVOLINEJAD H, Chirinos JA
   Use of Plasma Proteomics to Interrogate the Biologic Footprint of Ischemic Heart Disease in Heart Failure.
   Mayo Clin Proc. 2025;100:1095-1097.
   PubMed    
   
   
   
9. BAE JH, Choi J, Kim NH, Kim SG, et al
   In Reply: Ischemic Stroke, Type 2 Diabetes, Glucose-Lowering Drugs, and Cardiovascular Events.
   Mayo Clin Proc. 2025;100:1255-1257.
   PubMed    
   
   
   
10. FAUCHIER L, Lochon L, Guglieri M
    Ischemic Stroke, Type 2 Diabetes, Glucose-Lowering Drugs, and Cardiovascular Events.
    Mayo Clin Proc. 2025;100:1254-1255.
    PubMed    
    
    
    June 2025
11. NAGARAJA V, Rihal CS, Reeder G, Nath KA, et al
    Impact of Renal Function and Acute Kidney Injury on Long-term Outcomes After Percutaneous Coronary Intervention.
    Mayo Clin Proc. 2025 Jun 7:S0025-6196(25)00086.
    PubMed     Abstract available
    
    
    
12. ERGI DG, Crestanello JA, Holst K, Villavicencio Theoduloz MA, et al
    Obesity-Conduit Selection and Effect on Outcomes of Coronary Artery Bypass Grafting.
    Mayo Clin Proc. 2025 Jun 3:S0025-6196(25)00160.
    PubMed     Abstract available
    
    
    May 2025
13. SINGH M, Valgimigli M
    Pretreatment With P2Y(12) Inhibitors in Contemporary Practice: Where Do We Stand?
    Mayo Clin Proc. 2025;100:868-881.
    PubMed     Abstract available
    
    
    
14. ROZANSKI A, Gransar H, Miller RJH, Han D, et al
    Comparative Predictors of Mortality Risk in Contemporary Patients Referred for Stress Myocardial Perfusion Imaging.
    Mayo Clin Proc. 2025;100:828-839.
    PubMed     Abstract available
    
    
    April 2025
15. PEREYRA PIETRI M, Farina JM, Scalia IG, Roarke M, et al
    Characterization of Cardiovascular Events and Prognosis in Immune Checkpoint Inhibitor-Related Myocarditis.
    Mayo Clin Proc. 2025 Apr 9:S0025-6196(24)00693.
    PubMed     Abstract available
    
    
    March 2025
16. KUKU KO, Hashemian M, Joo J, Shearer JJ, et al
    Proteomic Profile of Ischemic Heart Disease in Heart Failure: A Community Study.
    Mayo Clin Proc. 2025 Mar 31:S0025-6196(24)00692.
    PubMed     Abstract available
    
    
    
17. BANACH M, Jaiswal V, Ang SP, Sawhney A, et al
    Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis.
    Mayo Clin Proc. 2025 Mar 20:S0025-6196(25)00075.
    PubMed     Abstract available
    
    
    
18. TIAN X, Zhang Y, Chen S, Xia X, et al
    Blood Pressure Time in Target Range Within 24 Hours and Cardiovascular Diseases and Mortality: Perspectives From a Real-World Cohort Study.
    Mayo Clin Proc. 2025 Mar 4:S0025-6196(24)00412.
    PubMed     Abstract available
    
    
    February 2025
19. SCHNOHR P, O'Keefe JH, Lavie CJ, Suetta C, et al
    Comparison of Muscle Strength and Cardiorespiratory Fitness in Relation to Cardiovascular and All-Cause Mortality: The Copenhagen City Heart Study.
    Mayo Clin Proc. 2025 Feb 5:S0025-6196(24)00413.
    PubMed     Abstract available
    
    
    
20. INGRAHAM BS, Valgimigli M, Angiolillo DJ, Capodanno D, et al
    Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
    Mayo Clin Proc. 2025;100:304-331.
    PubMed     Abstract available
    
    
    January 2025
21. ZHEUTLIN AR, Stulberg EL, Chaitoff A, Harris BRE, et al
    County-Level Social Determinants of Health and Coronary Heart Disease: An Ecological Analysis of US Adults.
    Mayo Clin Proc. 2025 Jan 13:S0025-6196(24)00490.
    PubMed    
    
    
    
22. BAE JH, Choi J, Kim NH, Kim SG, et al
    Cardiovascular Outcomes With Antidiabetic Drugs in People With Type 2 Diabetes and a Prior Stroke.
    Mayo Clin Proc. 2025 Jan 11:S0025-6196(24)00415.
    PubMed     Abstract available
    
    
    
23. SHETTY NS, Gaonkar M, Patel N, Vekariya N, et al
    PREVENT and Pooled Cohort Equations in Atherosclerotic Cardiovascular Disease Risk Prediction: A Post Hoc Analysis of SPRINT.
    Mayo Clin Proc. 2025 Jan 4:S0025-6196(24)00426.
    PubMed    
    
    
    December 2024
24. KIDANE RD, Ruddy KJ, Lin G, Sandhu NP, et al
    Cardiovascular Health Considerations for Primary Care Physicians Treating Breast Cancer Survivors.
    Mayo Clin Proc. 2024 Dec 4:S0025-6196(24)00414.
    PubMed     Abstract available
    
    
    November 2024
25. INGRAHAM BS, Huxley SB, Lane CM, Gulati R, et al
    Genotype-Guided P2Y(12) Inhibitor Monotherapy Within 7 Days of Percutaneous Coronary Intervention in High Bleeding Risk Patients: The CHAMP Trial - A Pilot Study and Safety Assessment.
    Mayo Clin Proc. 2024 Nov 26:S0025-6196(24)00307.
    PubMed     Abstract available
    
    
    
26. ISMAYL M, Raphael CE, Prasad A, Chareonthaitawee P, et al
    Agreement of Doppler Flow Velocity Reserve With PET Flow Reserve in Patients With Angina Without Obstructive Coronary Arteries.
    Mayo Clin Proc. 2024 Nov 12:S0025-6196(24)00403.
    PubMed    
    
    
    October 2024
27. TIMSANS J, Kerola AM, Rantalaiho VM, Hakkarainen KN, et al
    "Metabolic" Type of Hyperuricemia Increases Mortality Mainly by Leading to Premature Death From Cardiovascular Disease.
    Mayo Clin Proc. 2024 Oct 9:S0025-6196(24)00355.
    PubMed    
    
    
    
28. MORGENTALER A, Dhindsa S, Dobs AS, Hackett G, et al
    Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy.
    Mayo Clin Proc. 2024 Oct 9:S0025-6196(24)00408.
    PubMed     Abstract available
    
    
    September 2024
29. DENBY KJ, Zmaili M, Datta S, Das T, et al
    Developments and Controversies in Invasive Diagnosis of Coronary Microvascular Dysfunction in Angina With Nonobstructive Coronary Arteries.
    Mayo Clin Proc. 2024;99:1469-1481.
    PubMed     Abstract available
    
    
    August 2024
30. WANG Z, VanderPluym JH, Halker Singh RB, Alsibai RA, et al
    Safety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease: A Target Trial Emulation.
    Mayo Clin Proc. 2024 Aug 29:S0025-6196(24)00164.
    PubMed     Abstract available
    
    
    
31. WANG J, Ye Y, Chen X, Hu X, et al
    Trends in Statin Use for the Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults by Age, 1999-2020.
    Mayo Clin Proc. 2024 Aug 9:S0025-6196(24)00305.
    PubMed    
    
    
    
32. SHETTY NS, Gaonkar M, Pampana A, Patel N, et al
    Genetic Risk and Coronary Artery Calcium in Personalizing Antihypertensive Treatment: A Pooled Cohort Analysis.
    Mayo Clin Proc. 2024 Aug 7:S0025-6196(24)00027.
    PubMed     Abstract available
    
    
    
33. KOHLER TS, Kloner RA, Rosen RC, Burnett AL, et al
    The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease.
    Mayo Clin Proc. 2024 Aug 7:S0025-6196(24)00276.
    PubMed     Abstract available
    
    
    
34. LIN DS, Huang KC, Lin TT, Lee JK, et al
    Effects of Colchicine on Major Adverse Limb and Cardiovascular Events in Patients With Peripheral Artery Disease.
    Mayo Clin Proc. 2024 Aug 6:S0025-6196(24)00249.
    PubMed     Abstract available
    
    
    July 2024
35. WRIGHT RS, Ray KK, Landmesser U, Koenig W, et al
    Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials.
    Mayo Clin Proc. 2024 Jul 5:S0025-6196(24)00167.
    PubMed     Abstract available
    
    
    
36. VALLABHAJOSYULA S, Abbott JD, Kapur NK
    The Need to Define High-Dose Pharmacological Circulatory Support in Cardiogenic Shock.
    Mayo Clin Proc. 2024;99:1035-1037.
    PubMed    
    
    
    
37. ABDELAZIZ A, Hafez A, Abdelaziz M, Atta K, et al
    Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories: A Systematic Review and Meta-analysis.
    Mayo Clin Proc. 2024;99:1188-1191.
    PubMed    
    
    
    June 2024
38. TAN NY, Asirvatham SJ
    Preoperative Atrial Fibrillation in Coronary Artery Bypass Grafting Patients: Evidence and Gaps.
    Mayo Clin Proc. 2024;99:864-866.
    PubMed    
    
    
    
39. KUNUTSOR SK, Laukkanen JA
    A U-Shaped Challenge: Addressing Cardiovascular Outcomes in Cancer Patients With Body Mass Index Changes.
    Mayo Clin Proc. 2024;99:861-863.
    PubMed    
    
    
    May 2024
40. HAWKINS-VAN DER CINGEL G, Walsh SB, Eckardt KU, Knauf F, et al
    Oxalate Metabolism: From Kidney Stones to Cardiovascular Disease.
    Mayo Clin Proc. 2024 May 16:S0025-6196(24)00090.
    PubMed     Abstract available
    
    
    
41. BHATTA DN, Bommer W
    Trends in California Cardiovascular Disease Mortality: Sex-Race/Ethnicity Disparity and Income Inequality.
    Mayo Clin Proc. 2024 May 13:S0025-6196(24)00104.
    PubMed     Abstract available
    
    
    
42. UENO K, Kaneko H, Suzuki Y, Okada A, et al
    Change in Body Mass Index and Cardiovascular Outcomes in Patients With Cancer.
    Mayo Clin Proc. 2024 May 4:S0025-6196(24)00087.
    PubMed     Abstract available
    
    
    April 2024
43. TALMOR-BARKAN Y, Yu J, Yacovzada NS, Pravda NS, et al
    Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study.
    Mayo Clin Proc. 2024 Apr 26:S0025-6196(24)00028.
    PubMed     Abstract available
    
    
    
44. DABROWSKI EJ, Kurasz A, Pasierski M, Pannone L, et al
    Surgical Coronary Revascularization in Patients With Underlying Atrial Fibrillation: State-of-the-Art Review.
    Mayo Clin Proc. 2024 Apr 24:S0025-6196(23)00606.
    PubMed     Abstract available
    
    
    
45. SPARKS JR, Wang X, Lavie CJ, Zhang J, et al
    Cardiorespiratory Fitness as a Predictor of Non-Cardiovascular Disease and Non-Cancer Mortality in Men.
    Mayo Clin Proc. 2024 Apr 24:S0025-6196(23)00599.
    PubMed     Abstract available
    
    
    
46. BAINS S, Giudicessi JR, Odening KE, Ackerman MJ, et al
    State of Gene Therapy for Monogenic Cardiovascular Diseases.
    Mayo Clin Proc. 2024;99:610-629.
    PubMed     Abstract available
    
    
    March 2024
47. KNOTT JD, Ola O, De Michieli L, Akula A, et al
    High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction.
    Mayo Clin Proc. 2024 Mar 15:S0025-6196(24)00026.
    PubMed     Abstract available
    
    
    
48. MOSHKOVITZ Y, Orenstein L, Olmer L, Laufer K, et al
    Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery.
    Mayo Clin Proc. 2024 Mar 6:S0025-6196(23)00341.
    PubMed     Abstract available
    
    
    
49. SHARMA S, Johnson E, Goswami R
    Congenital Absence of Right Coronary Artery.
    Mayo Clin Proc. 2024 Mar 6:S0025-6196(23)00480.
    PubMed    
    
    
    
50. SOROOSH G, Dardari Z, Howard-Claudio C, Lutsey P, et al
    Older Adults' Perceptions of Their Risk and Its Correlation With Coronary Atherosclerosis Burden.
    Mayo Clin Proc. 2024;99:508-510.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.